Susquehanna International Group
TTPH

Susquehanna International Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Susquehanna International Group’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13,220
Closed -$730K – 10429
2018
Q3 		$730K Buy
13,220
+10,340
+359% +$660K ﹤0.01% 5861
2018
Q2 		$206K Buy
2,880
+355
+14% +$25.1K ﹤0.01% 8568
2018
Q1 		$155K Sell
2,525
-875
-26% -$76.8K ﹤0.01% 8509
2017
Q4 		$428K Buy
3,400
+615
+22% +$78.8K ﹤0.01% 6923
2017
Q3 		$381K Sell
2,785
-1,130
-29% -$151K ﹤0.01% 7001
2017
Q2 		$558K Buy
3,915
+3,345
+587% +$517K ﹤0.01% 6441
2017
Q1 		$105K Sell
570
-835
-59% -$93.6K ﹤0.01% 8365
2016
Q4 		$113K Buy
1,405
+230
+20% +$18.2K ﹤0.01% 9022
2016
Q3 		$90K Sell
1,175
-605
-34% -$48.5K ﹤0.01% 7980
2016
Q2 		$153K Sell
1,780
-3,420
-66% -$313K ﹤0.01% 7806
2016
Q1 		$482K Buy
5,200
+360
+7% +$36K ﹤0.01% 6465
2015
Q4 		$971K Sell
4,840
-9,180
-65% -$1.83M ﹤0.01% 5461
2015
Q3 		$2.09M Buy
14,020
+8,340
+147% +$6.12M ﹤0.01% 4188
2015
Q2 		$5.39M Buy
5,680
+1,035
+22% +$846K ﹤0.01% 2800
2015
Q1 		$3.4M Buy
4,645
+2,505
+117% +$1.88M ﹤0.01% 3328
2014
Q4 		$1.7M Sell
2,140
-720
-25% -$388K ﹤0.01% 4770
2014
Q3 		$1.14M Buy
2,860
+635
+29% +$170K ﹤0.01% 5686
2014
Q2 		$600K Buy
+2,225
New +$477K ﹤0.01% 7127

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Susquehanna International Group's TTPH Position: Q2 2019 in Review

Susquehanna International Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 1,168 shares — an estimated $31K sold.

Susquehanna International Group first reported a position in TTPH in Q2 2013 and held it in 17 quarters. The position peaked at $4.2M in Q2 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

  • Susquehanna International Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Susquehanna International Group sold 1,168 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $31K.
  • Susquehanna International Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
  • Susquehanna International Group's Tetraphase Pharmaceuticals, Inc. position peaked at $4.2M in Q2 2015.
  • 66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.